Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Krasny Oktyabr reported for 6 months of 2024 by RAS

7/24/24 KROT

Novatek reports for 6 months of 2024 by RAS

7/24/24 NVTK

NPF Tinkoff Pension is preparing to launch

7/24/24 T

Mosenergo increased electricity generation by 6.7%

7/24/24 MSNG

RusHydro's output grew by 7% in the 1st half of the year

7/24/24 HYDR

LSR reported for 6 months of 2024 by RAS

7/24/24 LSRG

Ashinskiy Metzavod reported for 6 months of 2024 by RAS

7/24/24 AMEZ

MMK reported for 6 months of 2024 by RAS

7/24/24 MAGN

Novatek reports for 6 months of 2024 by IFRS

7/24/24 NVTK

Sovcombank held an SPO and increased to 10%

7/24/24 SVCB